Article citationsMore>>

Brose, M.S., Worden, F.P., Newboid, K.L., Guo, M. and Hurria, A. (2017) Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SLECT Trial. Journal of Clinical Oncology, 35, 2692-2699.
https://doi.org/10.1200/JCO.2016.71.6472

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top